| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.0M | — |
| Cost of Revenue | $752K | — |
| Gross Profit | $1.3M | — |
| R&D Expense | $72.1M | +135.2% |
| SG&A Expense | $38.4M | -19.1% |
| Operating Income | -$109.2M | -39.8% |
| Pre-tax Income | -$100.0M | -84.3% |
| Income Tax | $188K | +122.0% |
| Net Income | -$100.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $128.8M | +50.3% |
| Accounts Receivable | $950K | — |
| Inventory | $212K | -62.0% |
| Current Assets | $276.9M | -20.6% |
| Total Assets | $329.8M | -18.9% |
| Current Liabilities | $22.8M | +12.1% |
| Total Liabilities | $51.5M | +7.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$66.1M | -17.1% |
| Capital Expenditures | $12.2M | -22.6% |
| Investing Cash Flow | $108.2M | +230.7% |
| Financing Cash Flow | $1.0M | -69.2% |
| Free Cash Flow | -$78.3M | -8.5% |
| -87.6% |
| EPS (Basic) | -$0.31 | -82.4% |
| EPS (Diluted) | -$0.31 | -82.4% |
| Stockholders' Equity |
| $278.3M |
| -22.5% |